Cargando…
The dose of inhaled corticosteroids in patients with COPD: when less is better
BACKGROUND: The use of inhaled corticosteroids (ICS) in combination with bronchodilators in patients with COPD has been shown to decrease the rate of disease exacerbations and to improve the lung function and patients’ quality of life. However, their use has also been associated with an increased ri...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207269/ https://www.ncbi.nlm.nih.gov/pubmed/30498343 http://dx.doi.org/10.2147/COPD.S175047 |